# OnCo record apmonia-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/apmonia-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "apmonia-therapeutics" ;
  schema:name "Apmonia Therapeutics"@en ;
  schema:description "Apmonia Therapeutics makes small ring-shaped peptides aimed at the tissue around tumours. Its first medicine blocks a signal that helps tumours suppress the immune system, and is starting its first trial in people with advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/apmonia-therapeutics/>, <https://apmonia-therapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://apmonia-therapeutics.com/>, <https://apmonia-therapeutics.com/index.php/about-us/>, <https://apmonia-therapeutics.com/index.php/2026/02/03/apmonia-therapeutics-secures-e10-million-to-advance-first-in-human-development-of-first-in-class-cancer-therapy-tax2/>, <https://clinicaltrials.gov/study/NCT07688148> ;
  schema:addressCountry "FR" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cd47-blockade/> ;
  onco:targets <https://onco.cc/targets/cd47/> .